Trademark search for:

MELTACIB

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2014-03-17 — Application filed
2014-03-20 — Application filed
2014-04-01 — Application filed
2014-04-02 — Notice of pseudo mark e-mailed
2014-06-10 — Approved for pub - principal register
2014-06-10 — Assigned to examiner
2014-06-25 — Notification of notice of publication e-mailed
2014-07-15 — Published for opposition
2014-07-15 — Official gazette publication confirmation e-mailed
2014-07-18 — Teas delete 1(b) basis received
2014-07-18 — Post publication amendment received
2014-08-18 — Assigned to petition staff
2014-08-19 — Withdrawn from pub - petitions office request
2014-08-19 — Post publication amendment - entered
2014-09-03 — Notification of notice of publication e-mailed
2014-09-23 — Published for opposition
2014-09-23 — Official gazette publication confirmation e-mailed
2014-12-09 — Registered-principal register
2016-03-31 — Teas change of correspondence received
2019-12-09 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2021-07-16 — Cancelled sec. 8 (6-yr)
2021-07-16 — Final status recorded

Owner Information

Sanofi
Paris FR

Correspondent

MIDGE M. HYMAN COWAN, LIEBOWITZ & LATMAN, P.C.
114 West 47th Street
NEW YORK, NY 10036-1525
UNITED STATES

Filing Details

Filing Date:
2014-03-17

Status Date:
2021-07-16

Category:
Pharmaceuticals

Filing Year:
2007

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.